Learn about the Johnson & Johnson COVID-19 vaccine developed by J&J subsidiary Janssen in this post by Nidhi Parekh of The Shared Microscope.
The winter flu season is going to be a difficult few months in the ongoing COVID-19 pandemic. In this post, Sheeva Azma breaks down the timeline of science research that is occuring and when a COVID-19 vaccine or curative therapy might be available.
In this post, Nidhi Parekh of The Shared Microscope discusses the vaccine in development by Pfizer and BioNTech — an mRNA-based vaccine that is considered a “dark horse” in the COVID-19 vaccine race.
In this post, Fancy Comma, LLC’s Sheeva Azma reflects on the state of biomedical science journalism in the COVID-19 pandemic.
In this post, Nidhi Parekh of The Shared Microscope talks about Novavax, a protein subunit vaccine being developed for COVID-19.
Learn more about CoronaVac, a COVID-19 inactivated vaccine being developed by Sinovac in China, in this post by Nidhi Parekh of The Shared Microscope.
Is a post-COVID-19 world possible? Will COVID-19 become endemic? Should we have done it all differently? What about a vaccine? What are the major troubles we are facing? Nidhi Parekh of The Shared Microscope examines what the experts have to say on these questions.
We speak to a participant in the Oxford/AstraZeneca vaccine trials for COVID-19 about what it’s like.
Nidhi Parekh of The Shared Microscope discusses the history of, and science behind, the Oxford/AstraZeneca vaccine for COVID-19.
In this post, learn about how the Moderna COVID-19 vaccine works. and why this mRNA-based vaccine is a front-runner in the race to a COVID-19 vaccine to mitigate the ongoing novel coronavirus pandemic.